Respiratory syncytial virus infections enhance cigarette smoke induced COPD in mice

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Foronjy, Robert F ^a   Dabo, Abdoulaye J ^a   Taggart, Clifford C ^b   Weldon, Sinead ^b   Geraghty, Patrick ^a  

^a ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN E; CATHEPSIN S; CATHEPSIN W; CATHEPSIN X; CIGARETTE SMOKE; COLLAGENASE 3; CXCL1 CHEMOKINE; CXCL9 CHEMOKINE; GELATINASE A; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 1ALPHA; MACROPHAGE ELASTASE; MACROPHAGE INFLAMMATORY PROTEIN; MATRIX METALLOPROTEINASE 16; NEUTROPHIL COLLAGENASE; PHOSPHOPROTEIN PHOSPHATASE 2A; PROTEIN TYROSINE PHOSPHATASE 1B; RANTES; CATHEPSIN; CYTOKINE; PEPTIDE HYDROLASE; PHOSPHOPROTEIN PHOSPHATASE 2; PTPN1 PROTEIN, MOUSE; SMOKE;

AIRWAY REMODELING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CYTOKINE RELEASE; GENE EXPRESSION; LONG TERM EXPOSURE; LUNG FIBROSIS; LYMPHOCYTIC INFILTRATION; MACROPHAGE MIGRATION; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PNEUMONIA; PROTEIN EXPRESSION; RECURRENT INFECTION; RESPIRATORY SYNCYTIAL VIRUS INFECTION; ADVERSE EFFECTS; ANIMAL; C57BL MOUSE; CHEMISTRY; GENE EXPRESSION REGULATION; GENETICS; HOST PATHOGEN INTERACTION; HUMAN; HUMAN RESPIRATORY SYNCYTIAL VIRUS; IMMUNOBLOTTING; LUNG; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOKE; TOBACCO; TUMOR CELL LINE; VIROLOGY;

ANIMALS; APOPTOSIS; CATHEPSINS; CELL LINE, TUMOR; CYTOKINES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNOBLOTTING; LUNG; MICE, INBRED C57BL; PEPTIDE HYDROLASES; PNEUMONIA; PROTEIN PHOSPHATASE 2; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SMOKE; TOBACCO;

EID: 84896284961     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0090567     Document Type: Article

References (75)

1. Miniño AM, Xu J, Kochanek KD (2010) Deaths: Preliminary Data for 2008. National Vital Statistics Reports 59: 1-72.
2. Sin DD, Stafinski T, Ng YC, Bell NR, Jacobs P (2002) The impact of chronic obstructive pulmonary disease on work loss in the United States. Am J Respir Crit Care Med 165: 704-707. (Pubitemid 34194761)
3. DiBonaventura M, Paulose-Ram R, Su J, McDonald M, Zou KH, et al. (2012) The impact of COPD on quality of life, productivity loss, and resource use among the elderly United States workforce. COPD 9: 46-57.
4. Langsetmo L, Platt RW, Ernst P, Bourbeau J (2008) Underreporting exacerbation of chronic obstructive pulmonary disease in a longitudinal cohort. Am J Respir Crit Care Med 177: 396-401. (Pubitemid 351317582)
5. Donaldson GC, Seemungal TA, Bhowmik A, Wedzicha JA (2002) Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 57: 847-852. (Pubitemid 35178607)
6. Soler-Cataluna JJ, Martinez-Garcia MA, Roman Sanchez P, Salcedo E, Navarro M, et al. (2005) Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax 60: 925-931. (Pubitemid 41598207)
7. Miravitlles M, Anzueto A, Legnani D, Forstmeier L, Fargel M (2007) Patient's perception of exacerbations of COPD-the PERCEIVE study. Respir Med 101: 453-460. (Pubitemid 46196335)
8. Wedzicha JA (2001) Airway infection accelerates decline of lung function in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 164: 1757-1758. (Pubitemid 33152304)
9. Mallia P, Johnston SL (2005) Mechanisms and experimental models of chronic obstructive pulmonary disease exacerbations. Proc Am Thorac Soc 2: 361-366; discussion 371-362. (Pubitemid 41699697)
10. Sajjan US (2013) Susceptibility to viral infections in chronic obstructive pulmonary disease: role of epithelial cells. Curr Opin Pulm Med 19: 125-132.
11. Zhang L, Peeples ME, Boucher RC, Collins PL, Pickles RJ (2002) Respiratory syncytial virus infection of human airway epithelial cells is polarized, specific to ciliated cells, and without obvious cytopathology. J Virol 76: 5654-5666. (Pubitemid 34517916)
12. Falsey AR, Hennessey PA, Formica MA, Cox C, Walsh EE (2005) Respiratory syncytial virus infection in elderly and high-risk adults. N Engl J Med 352: 1749-1759. (Pubitemid 40570923)
13. (2004) Respiratory syncytial virus activity-United States, 2003-2004. MMWR Morb Mortal Wkly Rep 53: 1159-1160.
14. Seemungal T, Harper-Owen R, Bhowmik A, Moric I, Sanderson G, et al. (2001) Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 164: 1618-1623. (Pubitemid 33124148)
15. Wilkinson TM, Donaldson GC, Johnston SL, Openshaw PJ, Wedzicha JA (2006) Respiratory syncytial virus, airway inflammation, and FEV1 decline in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 173: 871-876.
16. Cody SH (2013) Editorial Commentary: Rapid Detection and Investigation of an Outbreak of Escherichia coli O157:H7 Infections: Shoe-leather Epidemiology on and Around the Strawberry Farm. Clin Infect Dis 57: 1135-1137.
17. Sikkel MB, Quint JK, Mallia P, Wedzicha JA, Johnston SL (2008) Respiratory syncytial virus persistence in chronic obstructive pulmonary disease. Pediatr Infect Dis J 27: S63-70.
18. Modestou MA, Manzel LJ, El-Mahdy S, Look DC (2010) Inhibition of IFNgamma-dependent antiviral airway epithelial defense by cigarette smoke. Respir Res 11:
19. Robbins CS, Dawe DE, Goncharova SI, Pouladi MA, Drannik AG, et al. (2004) Cigarette smoke decreases pulmonary dendritic cells and impacts antiviral immune responsiveness. Am J Respir Cell Mol Biol 30: 202-211. (Pubitemid 38147205)
20. Mehta J, Walsh EE, Mahadevia PJ, Falsey AR (2013) Risk factors for respiratory syncytial virus illness among patients with chronic obstructive pulmonary disease. COPD 10: 293-299.
21. Kang MJ, Lee CG, Lee JY, Dela Cruz CS, Chen ZJ, et al. (2008) Cigarette smoke selectively enhances viral PAMP-and virus-induced pulmonary innate immune and remodeling responses in mice. J Clin Invest 118: 2771-2784.
22. Bauer CM, Zavitz CC, Botelho FM, Lambert KN, Brown EG, et al. (2010) Treating viral exacerbations of chronic obstructive pulmonary disease: insights from a mouse model of cigarette smoke and H1N1 influenza infection. PLoS One 5: e13251.
23. DiFranza JR, Masaquel A, Barrett AM, Colosia AD, Mahadevia PJ (2012) Systematic literature review assessing tobacco smoke exposure as a risk factor for serious respiratory syncytial virus disease among infants and young children. BMC Pediatr 12:65
24. Lee N, Lui GC, Wong KT, Li TC, Tse EC, et al. (2013) High morbidity and mortality in adults hospitalized for respiratory syncytial virus infections. Clin Infect Dis 57: 1069-1077.
25. Boukhvalova MS, Yim KC, Prince GA, Blanco JC (2010) Methods for monitoring dynamics of pulmonary RSV replication by viral culture and by realtime reverse transcription-PCR in vivo: Detection of abortive viral replication. Curr Protoc Cell Biol Chapter 26: Unit26
26. Foronjy RF, Mirochnitchenko O, Propokenko O, Lemaitre V, Jia Y, et al. (2006) Superoxide dismutase expression attenuates cigarette smoke-or elastasegenerated emphysema in mice. Am J Respir Crit Care Med 173: 623-631. (Pubitemid 43363803)
27. Hsia CCW, Hyde DM, Ochs M, Weibel ER and on behalf of the ATS/ERS Joint Task Force on the Quantitative Assessment of Lung Structure (2010) An Official Research Policy Statement of the American Thoracic Society/European Respiratory Society: Standards for Quantitative Assessment of Lung Structure. Am J Respir Crit Care Med 181: 394-418.
28. Ford JG, Rennick D, Donaldson DD, Venkayya R, McArthur C, et al. (2001) Il-13 and IFN-gamma: interactions in lung inflammation. J Immunol 167: 1769-1777. (Pubitemid 32703181)
29. Mehra D, Geraghty PM, Hardigan AA, Foronjy R (2012) A comparison of the inflammatory and proteolytic effects of dung biomass and cigarette smoke exposure in the lung. PLoS ONE 7: e52889.
30. Ashcroft T, Simpson JM, Timbrell V (1988) Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J Clin Pathol 41: 467-470. (Pubitemid 18098428)
31. De Langhe E, Vande Velde G, Hostens J, Himmelreich U, Nemery B, et al. (2012) Quantification of lung fibrosis and emphysema in mice using automated micro-computed tomography. PLoS One 7: e43123.
32. Geraghty P, Greene CM, O'Mahony M, O'Neill SJ, Taggart CC, et al. (2007) Secretory leucocyte protease inhibitor inhibits interferon-gamma-induced cathepsin S expression. J Biol Chem 282: 33389-33395. (Pubitemid 350159551)
33. D'Armiento JM, Goldklang MP, Hardigan AA, Geraghty P, Roth MD, et al. (2013) Increased matrix metalloproteinase (MMPs) levels do not predict disease severity or progression in emphysema. PLoS ONE 8: e56352.
34. Geraghty P, Rogan MP, Greene CM, Boxio RM, Poiriert T, et al. (2007) Neutrophil elastase up-regulates cathepsin B and matrix metalloprotease-2 expression. J Immunol 178: 5871-5878. (Pubitemid 46674384)
35. Geraghty P, Hardigan AA, Wallace AM, Mirochnitchenko O, Thankachen J, et al. (2013) The glutathione peroxidase 1-protein tyrosine phosphatase 1B-protein phosphatase 2A axis. A key determinant of airway inflammation and alveolar destruction. Am J Respir Cell Mol Biol 49: 721-730.
36. Zhou Y, Kang MJ, Jha BK, Silverman RH, Lee CG, et al. (2013) Role of ribonuclease L in viral pathogen-associated molecular pattern/influenza virus and cigarette smoke-induced inflammation and remodeling. J Immunol 191: 2637-2646.
37. Geraghty P, Rogan MP, Greene CM, Brantly ML, O'Neill SJ, et al. (2008) Alpha-1-antitrypsin aerosolised augmentation abrogates neutrophil elastaseinduced expression of cathepsin B and matrix metalloprotease 2 in vivo and in vitro. Thorax 63: 621-626. (Pubitemid 351969256)
38. Groskreutz DJ, Monick MM, Babor EC, Nyunoya T, Varga SM, et al. (2009) Cigarette smoke alters respiratory syncytial virus-induced apoptosis and replication. Am J Respir Cell Mol Biol 41: 189-198.
39. Wallace AM, Hardigan A, Geraghty P, Salim S, Gaffney A, et al. (2012) Protein phosphatase 2A regulates innate immune and proteolytic responses to cigarette smoke exposure in the lung. Toxicol Sci 126: 589-599.
40. Collison A, Hatchwell L, Verrills N, Wark PA, de Siqueira AP, et al. (2013) The E3 ubiquitin ligase midline 1 promotes allergen and rhinovirus-induced asthma by inhibiting protein phosphatase 2A activity. Nat Med 19: 232-237.
41. Hirakawa S, Kojima T, Obata K, Okabayashi T, Yokota SI, et al. (2013) Marked induction of matrix metalloproteinase-10 by respiratory syncytial virus infection in human nasal epithelial cells. J Med Virol.
42. Schuurhof A, Bont L, Hodemaekers HM, de Klerk A, de Groot H, et al. (2012) Proteins involved in extracellular matrix dynamics are associated with respiratory syncytial virus disease severity. Eur Respir J 39: 1475-1481.
43. Elliott MB, Welliver RC Sr, Laughlin TS, Pryharski KS, LaPierre NA, et al. (2007) Matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in the respiratory tracts of human infants following paramyxovirus infection. J Med Virol 79: 447-456. (Pubitemid 46355446)
44. Yeo SJ, Yun YJ, Lyu MA, Woo SY, Woo ER, et al. (2002) Respiratory syncytial virus infection induces matrix metalloproteinase-9 expression in epithelial cells. Arch Virol 147: 229-242.
45. Li W, Shen HH (2007) Effect of respiratory syncytial virus on the activity of matrix metalloproteinase in mice. Chin Med J (Engl) 120: 5-11. (Pubitemid 46117576)
46. Shapiro SD (2003) Proteolysis in the lung. Eur Respir J Suppl 44: 30s-32s. (Pubitemid 37222059)
47. Zheng T, Kang MJ, Crothers K, Zhu Z, LiuW, et al. (2005) Role of cathepsin Sdependent epithelial cell apoptosis in IFN-gamma-induced alveolar remodeling and pulmonary emphysema. J Immunol 174: 8106-8115. (Pubitemid 40806322)
48. Houghton AM, Quintero PA, Perkins DL, Kobayashi DK, Kelley DG, et al. (2006) Elastin fragments drive disease progression in a murine model of emphysema. J Clin Invest 116: 753-759. (Pubitemid 43326884)
49. Schochett P, Mora R, Mark L, Butler M, Ingenito EP (1999) Calciumdependent degradation of surfactant protein A by activated neutrophils due to serine proteases. Exp Lung Res 25: 595-616. (Pubitemid 29517668)
50. LeVine AM, Gwozdz J, Stark J, Bruno M, Whitsett J, et al. (1999) Surfactant protein-A enhances respiratory syncytial virus clearance in vivo. J Clin Invest 103: 1015-1021. (Pubitemid 29169609)
51. Drannik AG, Nag K, Sallenave JM, Rosenthal KL (2013) Antiviral activity of trappin-2 and elafin in vitro and in vivo against genital herpes. J Virol 87: 7526-7538.
52. Gong D, Farley K, White M, Hartshorn KL, Benarafa C, et al. (2011) Critical role of serpinB1 in regulating inflammatory responses in pulmonary influenza infection. J Infect Dis 204: 592-600.
53. Nadigel J, Prefontaine D, Baglole CJ, Maltais F, Bourbeau J, et al. (2011) Cigarette smoke increases TLR4 and TLR9 expression and induces cytokine production from CD8(+) T cells in chronic obstructive pulmonary disease. Respir Res 12: 149.
54. Geraghty P, Dabo AJ, D'Armiento J (2011) TLR4 protein contributes to cigarette smoke-induced matrix metalloproteinase-1 (MMP-1) expression in chronic obstructive pulmonary disease. J Biol Chem 286: 30211-30218.
55. Wang Z, Zheng T, Zhu Z, Homer R, Riese RJ, et al. (2000) Interferon Gamma Induction of Pulmonary Emphysema in the Adult Murine Lung. J Exp Med 192: 1587-1599.
56. Zheng T, Zhu Z, Wang Z, Homer RJ, Ma B, et al. (2000) Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase-and cathepsindependent emphysema. J Clin Invest 106: 1081-1093.
57. Bafadhel M, McKenna S, Terry S, Mistry V, Reid C, et al. (2011) Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers. Am J Respir Crit Care Med 184: 662-671.
58. Maeno T, Houghton AM, Quintero PA, Grumelli S, Owen CA, et al. (2007) CD8+ T Cells are required for inflammation and destruction in cigarette smokeinduced emphysema in mice. J Immunol 178: 8090-8096. (Pubitemid 46898081)
59. Murdoch JR, Lloyd CM (2010) Resolution of allergic airway inflammation and airway hyperreactivity is mediated by IL-17-producing {gamma}{delta}T cells. Am J Respir Crit Care Med 182: 464-476.
60. Mallia P, Message SD, Gielen V, Contoli M, Gray K, et al. (2011) Experimental rhinovirus infection as a human model of chronic obstructive pulmonary disease exacerbation. Am J Respir Crit Care Med 183: 734-742.
61. Castro SM, Kolli D, Guerrero-Plata A, Garofalo RP, Casola A (2008) Cigarette smoke condensate enhances respiratory syncytial virus-induced chemokine release by modulating NF-kappa B and interferon regulatory factor activation. Toxicol Sci 106: 509-518.
62. Monick MM, Cameron K, Staber J, Powers LS, Yarovinsky TO, et al. (2005) Activation of the epidermal growth factor receptor by respiratory syncytial virus results in increased inflammation and delayed apoptosis. J Biol Chem 280: 2147-2158.
63. Thomas KW, Monick MM, Staber JM, Yarovinsky T, Carter AB, et al. (2002) Respiratory syncytial virus inhibits apoptosis and induces NF-kappa B activity through a phosphatidylinositol 3-kinase-dependent pathway. J Biol Chem 277: 492-501. (Pubitemid 34952084)
64. Groskreutz DJ, Monick MM, Yarovinsky TO, Powers LS, Quelle DE, et al. (2007) Respiratory syncytial virus decreases p53 protein to prolong survival of airway epithelial cells. J Immunol 179: 2741-2747.
65. Kotelkin A, Prikhod'ko EA, Cohen JI, Collins PL, Bukreyev A (2003) Respiratory syncytial virus infection sensitizes cells to apoptosis mediated by tumor necrosis factor-related apoptosis-inducing ligand. J Virol 77: 9156-9172. (Pubitemid 37011013)
66. O'Donnell D R, Milligan L, Stark JM (1999) Induction of CD95 (Fas) and apoptosis in respiratory epithelial cell cultures following respiratory syncytial virus infection. Virology 257: 198-207. (Pubitemid 29391813)
67. van den Berg E, van Woensel JB, Bos AP, Bem RA, Altemeier WA, et al. (2011) Role of the Fas/FasL system in a model of RSV infection in mechanically ventilated mice. Am J Physiol Lung Cell Mol Physiol 301: L451-460.
68. Morissette MC, Parent J, Milot J (2011) The emphysematous lung is abnormally sensitive to TRAIL-mediated apoptosis. Respir Res 12: 105.
69. Morissette MC, Vachon-Beaudoin G, Parent J, Chakir J, Milot J (2008) Increased p53 level, Bax/Bcl-x(L) ratio, and TRAIL receptor expression in human emphysema. Am J Respir Crit Care Med 178: 240-247.
70. Bem RA, Bos AP, Wosten-van Asperen RM, Bruijn M, Lutter R, et al. (2010) Potential role of soluble TRAIL in epithelial injury in children with severe RSV infection. Am J Respir Cell Mol Biol 42: 697-705.
71. Hosakote YM, Jantzi PD, Esham DL, Spratt H, Kurosky A, et al. (2011) Viralmediated inhibition of antioxidant enzymes contributes to the pathogenesis of severe respiratory syncytial virus bronchiolitis. Am J Respir Crit Care Med 183: 1550-1560.
72. Niture SK, Jaiswal AK (2012) Nrf2 protein up-regulates antiapoptotic protein Bcl-2 and prevents cellular apoptosis. J Biol Chem 287: 9873-9886.
73. Foronjy R, Mirochnitchenko O, Lemaitre V, Jia Y, Inouye M, et al. (2005) Transgenic Expression of Human CuZn Superoxide Dismutase Prevents Cigarette Smoke-Induced Inflammation and Emphysema Formation American Thoracic Society. San Diego, California.
74. Yang H, Chen X, Wang X, Li Y, Chen S, et al. (2013) Inhibition of PP2A Activity Confers a TRAIL-sensitive Phenotype During Malignant Transformation. Mol Cancer Res.
75. Schneider D, Ganesan S, Comstock AT, Meldrum CA, Mahidhara R, et al. (2010) Increased cytokine response of rhinovirus-infected airway epithelial cells in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 182: 332-340.